ProQR Therapeutics BV (PRQR) Ownership

1.18 ↓0.09 (-6.75%)
As of November 29, 2022, 12:14pm EST.

Institutional Ownership

Privium Fund Management B.V. is the biggest individual institutional holder of ProQR Therapeutics BV (PRQR), owning a total of 5.3 million shares. Combined, the top 20 institutional holders of PRQR own 28.74% of the company with a total of 20.5 million shares.

In the latest ownership report on September 30th 2022, the top 20 institutional holders increased their combined ownership of PRQR by 646 thousand shares. 1 institutions bought 649,383 total additional shares and increased their ownership by an average of 0.00%. However 3 institutions sold 3,543 total shares and decreased their ownership by an average of 0.89%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of ProQR Therapeutics BV increased by a net total of 645,840 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Adage Capital Partners Gp LLC4.620%0.000%3,300,00002022-09-30
M28 Capital Management LP1.402%0.000%1,001,80002022-09-30
Monaco Asset Management1.304%0.000%931,40002022-09-30
Dafna Capital Management LLC0.909%0.000%649,383649,3832022-09-30
Goldman Sachs Group Inc0.221%-1.180%157,910-1,8862022-09-30
Franklin Street Advisors Inc.0.210%0.000%150,00002022-09-30
New York Life Investments Alternatives0.174%-0.678%124,424-8492022-09-30
Gilder Gagnon Howe & CO LLC0.136%-0.826%97,019-8082022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Privium Fund Management B.V.7.482%1.907%5,344,446100,0002022-06-30
Adage Capital Partners Gp LLC4.620%0.000%3,300,00002022-09-30
Opaleye Management Inc3.836%12.990%2,740,000315,0002022-06-30
Prosight Management, LP2.390%184.923%1,707,5091,108,2212022-06-30
Fidelity International Ltd1.481%-4.253%1,058,091-47,0022022-06-30
M28 Capital Management LP1.402%0.000%1,001,80002022-09-30
JPMorgan Chase & Co1.351%-1.338%964,714-13,0802022-06-30
Monaco Asset Management1.304%0.000%931,40002022-09-30
Renaissance Technologies Corp1.301%53.762%929,000324,8192022-06-30
Dafna Capital Management LLC0.909%0.000%649,383649,3832022-09-30
Two Sigma Investments LLC0.551%-47.171%393,248-351,1292022-06-30
Deutsche Bank AG0.539%0.000%385,20802022-06-30
Citadel Advisors Llc0.293%0.000%209,215209,2152022-06-30
Marshall Wace Asset Management Ltd0.240%0.000%171,172171,1722022-06-30
Goldman Sachs Group Inc0.221%-1.180%157,910-1,8862022-09-30
Franklin Street Advisors Inc.0.210%0.000%150,00002022-09-30
JANE STREET GROUP, LLC0.207%550.350%147,558124,8692022-06-30
New York Life Investments Alternatives0.174%-0.678%124,424-8492022-09-30
Gilder Gagnon Howe & CO LLC0.136%-0.826%97,019-8082022-09-30
Millennium Management LLC0.093%-89.982%66,157-594,2512022-06-30

Mutual Fund Ownership

Fidelity European Smlr Coms A-Dis-EUR is the biggest individual fund holder of ProQR Therapeutics BV (PRQR), owning a total of 899 thousand shares. Combined, the top 20 mutual fund holders of PRQR own 4.95% of the company with a total of 3.5 million shares.

In the latest ownership report on October 31st 2022, the top 20 fund holders increased their combined ownership of PRQR by 2 thousand shares. 1 funds bought 2,166 total additional shares and increased their ownership by an average of 0.48%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding ProQR Therapeutics BV increased by a net total of 2,166 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Biotechnology ETF0.633%0.481%452,2622,1662022-10-31
iShares Nasdaq US Biotech ETF USD Acc0.043%0.000%30,57602022-10-31
Invesco Nasdaq Biotechnology ETF0.002%0.000%1,46002022-10-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Fidelity European Smlr Coms A-Dis-EUR1.259%0.000%899,255-12022-07-31
Beleggingsfonds Hoofbosch0.980%0.000%700,00002022-07-31
Delaware Healthcare I0.868%0.000%620,00002022-09-30
iShares Biotechnology ETF0.633%0.481%452,2622,1662022-10-31
MEDICAL BioHealth EUR Acc0.602%0.000%429,78802022-07-31
Wellington CIF Biotechnology0.352%-3.660%251,441-9,5512022-03-31
RIM Global Bioscience EUR0.099%0.000%71,00002022-07-31
Fidelity® NASDAQ Composite Index®0.051%0.000%36,29302022-09-30
iShares Nasdaq US Biotech ETF USD Acc0.043%0.000%30,57602022-10-31
Sygnia 4th Industrial Revolution Gl Eq B0.019%0.000%13,27202022-03-31
Sygnia Itrix 4th IR Global Equity ETF0.016%0.000%11,30611,3062022-03-31
ProShares Ultra Nasdaq Biotechnology0.008%8.114%6,0094512022-07-31
NT Quality Small Cap Core0.006%0.000%4,13302022-09-30
NT Quality SCC US Fund - L0.006%0.000%4,13302022-09-30
Invesco Nasdaq Biotechnology ETF0.002%0.000%1,46002022-10-31
GF NASDAQ Bio-Tech Idx QDII RMB A0.001%0.000%74102022-06-30
BMO MSCI Genomic Innovation ETF0.001%0.000%56302022-09-30
BMO MSCI Innovation ETF0.001%0.000%48802022-09-30
CC&L Alternative Global Equity F0.000%0.000%4102022-03-31
CC&L Alternative Canadian Equity F0.000%0.000%4102022-03-31

Discussions

Please log in or register to share your thoughts.

substancetag

$PRQR low volume

expect flat or negative close

0 Like Report
kairaae

$PRQR holding unfortunately lol

0 Like Report